Abstract:Context: Psoriasis is a chronic, inflammation-mediated skin disease. The use of traditional Chinese medicine (TCM) in the treatment of psoriasis boasts a rich historical tradition. Researchers widely use network pharmacology to reveal the action mechanisms of TCM by establishing an interaction network-drug-component-target-disease. Objective: The study aimed to use a network pharmacology approach to investigate the interaction between TCM and its targets in psoriasis, aiming to identify core drugs and mechanisms underlying TCM's treatment of common psoriasis and to create a new TCM formula. Design: The research team performed a retrospective genetic study. Setting: The study took place in the Dermatology Department at Beijing Wangfu Hospital of Integrative Medicine in Beijing, China. Participants: Participants were patients that the dermatology clinic had diagnosed with common psoriasis between January 1, 2016 and January 1, 2019. Outcome measures: The research team: (1) calculated the frequency of each herb's occurrence; (2) identified the core drugs; (3) determined the core drugs' active ingredients and targets; (4) identified psoriasis' targets; (5) determined the target proteins; (6) identified the top-30, key signaling-set pathways; (7) identified the top 10 biological processes (BPs), cell components (CC), and molecular functions (MF); (8) screened the top-five major active ingredients; and (9) performed molecular docking. Results: The research team: (1) based on 892 prescriptions from 95 patients, identified 161 herbal medicines, with Lonicerae Japonicae Flos, Herba Portulacae, Radix Gentianae, Bletilla striata, Raw Rehmanniae Radix, Dictamni Cortex, and Forsythia suspensa being core drugs; (2) found 58 active ingredients and 144 effective, target functional genes for the core drugs through network pharmacology screening, with 81 potential targets for psoriasis treatment; the core drugs for treatment may restore the keratin-forming cell function by inhibiting cancer-related pathways, the interleukin-17 (IL-17) signaling pathway, the tumor necrosis factor (TNF) signaling pathway, and the hypoxia-inducible factor-1 (HIF-1) signaling pathway; (3) using molecular docking, revealed high-affinity interactions between the active ingredients primuletin, luteolin, and wogonin and mitogen-activated protein kinase 8 (MAPK8), tumor protein 53 (TP53), and epidermal growth factor receptor (EGFR). Conclusions: The new TCM formula to be used in the current research team's hospital may act on MAPK8, TP53, and EGFR targets through active ingredients such as primuletin, kaempferol, luteolin, wogonin, and β-sitosterol, which involve several signaling pathways, such as the cancer signaling, TNF signaling pathway, HIF-1 signaling pathway, and endocrine resistance. The research provides a theoretical foundation for the clinical use of the new TCM formula.

PDTCM: A systems pharmacology platform of traditional Chinese medicine for psoriasis.

Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Network pharmacology approaches for research of Traditional Chinese Medicines

Network Pharmacology Analysis of Traditional Chinese Medicine for Treating Psoriasis: Identifying Core Components, Mechanisms, and Dosing Patterns

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

TCMNPAS: a comprehensive analysis platform integrating network formulaology and network pharmacology for exploring traditional Chinese medicine

Exploiture and Application of an Internet-Based Computation Platform for Integrative Pharmacology of Traditional Chinese Medicine

SYSTCM: A systemic web platform for objective identification of pharmacological effects based on interplay of "traditional Chinese Medicine-components-targets"

Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis

LTM-TCM: A comprehensive database for the linking of Traditional Chinese Medicine with modern medicine at molecular and phenotypic levels

NP-TCMtarget: a network pharmacology platform for exploring mechanisms of action of Traditional Chinese medicine

ccTCM: A quantitative component and compound platform for promoting the research of traditional Chinese medicine

TCMAnalyzer: A Chemo- and Bioinformatics Web Service for Analyzing Traditional Chinese Medicine

De novo engineering of nanoformulation from traditional Chinese medicine mixtures for psoriasis

Exploring the Effect of Xiao-Chai-Hu Decoction on Treating Psoriasis Based on Network Pharmacology and Experiment Validation

An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula,Qing-Luo-Yin

MicrobeTCM: A comprehensive platform for the interactions of microbiota and traditional Chinese medicine

Modular pharmacology-based approach to identify hub genes and kernel pathways of taodan granules treated psoriasis

In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine

Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery

A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction